RBMY3AP

Across TCGA pan-cancer cohorts, RBMY3AP RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RBMY3AP data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RBMY3AP RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RBMY3AP expression acts as an unfavorable survival marker, although some lineages such as BLCA and TGCT show a favorable association.

BLCA, LUAD, and BRCA are the cancer types where RBMY3AP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.772	0.254	.005	69	view →
LUAD	OS	Tertile	All	0.386	0.689	.007	36	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
KIRC	OS	Tertile	II,III,IV	0.352	0.810	.018	21	view →
KIRP	OS	Tertile	All	0.832	0.947	.008	21	view →
DLBC	DFS	Tertile	All	0.399	0.796	.032	18	view →
LIHC	DFS	Tertile	All	0.249	0.463	.003	18	view →
TGCT	DFS	Median	All	0.937	0.774	.023	16	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
STAD	OS	Tertile	All	0.487	0.678	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RBMY3AP–BLCA (DFS)

Open the BLCA breakdown →